(S,R,S)-AHPC-C4-NH2 dihydrochloride is a high-quality E3 Ligase Ligand-Linker Conjugate designed for advanced PROTAC (Proteolysis Targeting Chimera) drug discovery and development. This compound incorporates the AHPC-based ligand, which selectively recruits the Von Hippel-Lindau (VHL) E3 ubiquitin ligase, connected via a C4 alkyl linker to a terminal amine (NH2) functional group, all supplied as a stable dihydrochloride salt. As a versatile building block, (S,R,S)-AHPC-C4-NH2 dihydrochloride enables researchers to synthesize custom PROTACs for targeted protein degradation—offering a powerful tool for exploring new therapeutic strategies against cancer, neurodegenerative disorders, and other diseases driven by pathogenic proteins. Its optimized linker length and functionalization facilitate efficient conjugation to diverse target ligands, making it a preferred choice in the category of E3 ligase ligand-linker conjugates for structure-activity studies. Unlock the next generation of chemical biology with this essential reagent for PROTAC research.
Structure of 2341796-78-7
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-C4-NH2 dihydrochloride is a specialized E3 ligase ligand-linker conjugate widely utilized in PROTAC (Proteolysis Targeting Chimeras) research. It features the AHPC (aryl hydroxyproline-based cereblon ligand) moiety connected through a C4 linker to an amine functional group, making it ideal for the modular assembly of targeted protein degraders. Its high purity and convenient solubility make it a popular choice for medicinal chemistry, chemical biology, and early-stage drug discovery applications.
Mechanism
(S,R,S)-AHPC-C4-NH2 dihydrochloride operates by harnessing the ubiquitin-proteasome system via cereblon (CRBN) E3 ligase recruitment. In PROTAC design, the AHPC-C4 moiety acts as the E3 ligase-recruiting warhead, while the linker terminus (NH2) facilitates covalent coupling to a ligand targeting the protein of interest. Upon bifunctional assembly, the resulting PROTAC molecule brings the target protein and CRBN E3 ligase into close proximity, promoting ubiquitination and subsequent proteasomal degradation of the target. This targeted degradation mechanism enables selective and potent elimination of disease-related proteins.
Applications
(S,R,S)-AHPC-C4-NH2 dihydrochloride is extensively employed in the development of next-generation PROTACs for targeted protein degradation. Its applications include: (1) rational design and synthesis of PROTAC molecules targeting undruggable or pathogenic proteins in oncology, immunology, and neurodegenerative disorders; (2) chemical biology tool development for validating protein function through knockdown studies; (3) structure-activity relationship (SAR) exploration of linker architecture and E3 ligase selection; and (4) early drug discovery and preclinical research to identify and optimize degraders with improved selectivity, potency, and pharmacological profiles.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.